Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
An analysis of cell lines representing different stages of the B-cell differentiation pathway indicated that about 50% of the cell lines examined expressed exclusively wild type p53 protein. These lines therefore offer a convenient system to study the involvement of p53 in cell differentiation. When 70Z/3, a pre-B cell line which expresses wild type p53, was treated with the differentiation inducer lipopolysaccharide (LPS), it was seen that increased levels of p53 mRNA preceded specific changes in kappa (kappa) immunoglobulin expression. This increased expression of kappa specific mRNA, which was evaluated by specific PCR analysis, was blocked following transfection with mutant p53 coding plasmids. Treatment of 13A60, another cell line which endogenously expresses wild type p53, with LPS caused a secretion of IgA antibodies, also accompanied by increased p53 mRNA expression. The conclusion was that induction of B-cell differentiation involves the transcription of the p53 gene. This was further substantiated by experiments showing that differentiation of stable clones derived from the 70Z/3 cell line, harboring a p53-promoter-CAT plasmid, induced increased CAT activity. Furthermore, wild type p53 transactivated the promoter control sequences of the kappa light chain gene. Taken together, these results suggest that p53 is involved in B-cell differentiation, a pathway which involves DNA rearrangements that may be accompanied by generation of faulty DNA. The fact that wild type p53 was shown to function as a transcriptional factor, coupled with the notion that it is associated with DNA repair systems, may designate p53 as a control protein in the B-cell differentiation pathway.
Aloni-Grinstein
R
R
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Zan-Bar
I
I
Alboum
I
I
Goldfinger
N
N
Rotter
V
V
D000818:Animals; D001402:B-Lymphocytes / Q000737:chemistry / Q000473:pathology* / Q000502:physiology; D001483:Base Sequence; D002454:Cell Differentiation; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000473:pathology*; D015500:Chloramphenicol O-Acetyltransferase / Q000378:metabolism / Q000502:physiology; D004273:DNA, Neoplasm / Q000032:analysis / Q000235:genetics; D015870:Gene Expression / Q000235:genetics; D007070:Immunoglobulin A / Q000032:analysis / Q000378:metabolism; D007145:Immunoglobulin kappa-Chains / Q000032:analysis / Q000235:genetics / Q000502:physiology; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D010954:Plasmacytoma / Q000473:pathology; D010957:Plasmids; D016133:Polymerase Chain Reaction; D011401:Promoter Regions, Genetic / Q000235:genetics / Q000502:physiology; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D014157:Transcription Factors / Q000502:physiology; D014158:Transcription, Genetic / Q000235:genetics; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000502:physiology*; D015854:Up-Regulation
D004273:DNA, Neoplasm; D007070:Immunoglobulin A; D007145:Immunoglobulin kappa-Chains; D008070:Lipopolysaccharides; D012333:RNA, Messenger; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53; D015500:Chloramphenicol O-Acetyltransferase